D.med Healthcare Group, a German group of companies with a diversified global presence and a focus on healthcare, today proudly announced the divestment of its Brazilian dialysis operations.
This strategic decision marks a significant step in D.med’s journey, involving the transfer of acute dialysis operations in three federal states and two state-of-the-art dialysis clinics in Brazil. This move is part of D.med’s overarching strategy to develop high-quality healthcare projects that resonate with and attract global leaders in the healthcare industry.
“At D.med, our core strength lies in our capacity to not only initiate and develop high-end healthcare projects but also in strategically positioning them in the global market, making them highly sought-after by leading industry players. Also, by transferring our Brazilian dialysis operations, we are adhering to our strategic goals while ensuring that our patients continue to receive the highest standard of care”, affirmed Sven-Axel Krentorz, CEO of D.med Healthcare Group.
Going forward, D.med Healthcare Group is committed to continuing its strategy of maximizing the impact of its diverse investment portfolio. The Group focuses on identifying and nurturing innovative healthcare projects, aiming to introduce them into the international market, and thereby contributing to the global advancement of healthcare services.
For additional information about D.med Healthcare Group and its wide range of innovative healthcare initiatives, please visit www.dmed-healthcare.com.
Investor Relations:
Roberto Fernández Gómez – International Director of Operations
Email:
Media Contact:
Rabiaa Adalet – Head of Global Marketing & Communication
Email: